Jeremy Bender
About Jeremy Bender
Jeremy Bender is the Chief Executive Officer of Day One Biopharmaceuticals and has served as an Independent Board Member at Mereo BioPharma since 2020. He holds a B.S. in Biology from Stanford University, a Ph.D. in Microbiology and Immunology from the University of Colorado, and an MBA from the MIT Sloan School of Management.
Current Role at Day One Biopharmaceuticals
Jeremy Bender serves as the Chief Executive Officer of Day One Biopharmaceuticals, a position he has held since 2020. In this role, he oversees the company's strategic direction and operational management. Bender's leadership is informed by his extensive experience in the life sciences sector, particularly in strategic planning and program management. He also contributes to the company's governance as a member of the Audit and Finance committee.
Education and Expertise
Jeremy Bender has a strong educational background in the life sciences and business management. He earned a Bachelor of Science in Biological Sciences from Stanford University, followed by a Ph.D. in Microbiology and Immunology from the University of Colorado Anschutz Medical Campus. Additionally, he holds an MBA from the MIT Sloan School of Management. His academic credentials support his expertise in global product development and commercialization.
Professional Background
Bender has a diverse professional background in the life sciences industry. He began his career at Boston Consulting Group, where he worked as a Project Leader and Consultant. He later held various leadership roles, including Chief Business Officer at Sutro Biopharma and Chief Operating Officer at Tizona Therapeutics. Prior to his current position, he served as Vice President of Corporate Development at Gilead Sciences and Allos Therapeutics.
Board Memberships and Affiliations
In addition to his role at Day One Biopharmaceuticals, Jeremy Bender is an Independent Board Member at Mereo BioPharma, a position he has held since 2020. He also sits on the boards of Fusion Pharmaceuticals. His involvement in these organizations reflects his commitment to advancing the life sciences sector and contributing to corporate governance.
Achievements in Corporate Development
Throughout his career, Jeremy Bender has demonstrated significant achievements in corporate development within the life sciences sector. His roles have included Vice President of Corporate Development at Gilead Sciences and Allos Therapeutics, where he focused on strategic initiatives and business growth. His experience encompasses extensive program management and strategic planning, contributing to successful product development and commercialization.